INVOLVEMENT OF D1/D2 RECEPTORS ON 1-METHYL-B-CARBOLINE (HARMANE) INDUCED-AMNESIA IN THE STEP-DOWN PASSIVE AVOIDANCE TEST

æí

[1]  M. Zarrindast,et al.  Effects of cannabinoids infused into the dorsal hippocampus upon memory formation in 3-days apomorphine-treated rats , 2009, Neurobiology of Learning and Memory.

[2]  M. Zarrindast,et al.  Dorsal hippocampal dopamine receptors are involved in mediating ethanol state-dependent memory. , 2007, Life sciences.

[3]  M. Zarrindast,et al.  Influence of nitric oxide on morphine-induced amnesia and interactions with dopaminergic receptor agents , 2006, Physiology & Behavior.

[4]  D. Nutt,et al.  Characterization of [3H]Harmane Binding to Rat Whole Brain Membranes , 2003, Annals of the New York Academy of Sciences.

[5]  K. Mohanakumar,et al.  Serotonin synthesis inhibition in olivo-cerebellar system attenuates harmaline-induced tremor in Swiss albino mice , 2003, Behavioural Brain Research.

[6]  H. Homayoun,et al.  Morphine state-dependent learning: interactions with &agr;2-adrenoceptors and acute stress , 2003, Behavioural pharmacology.

[7]  M. Smolka,et al.  The levels of norharman are high enough after smoking to affect monoamineoxidase B in platelets. , 2002, European journal of pharmacology.

[8]  D. Fekkes,et al.  The impact of smoking and drinking on plasma levels of norharman , 2002, European Neuropsychopharmacology.

[9]  Chung-Soo Lee,et al.  Protective effect of harmaline and harmalol against dopamine‐ and 6‐hydroxydopamine‐induced oxidative damage of brain mitochondria and synaptosomes, and viability loss of PC12 cells , 2001, The European journal of neuroscience.

[10]  R. Coccurello,et al.  Effect of intra-accumbens dopamine receptor agents on reactivity to spatial and non-spatial changes in mice , 2000, Psychopharmacology.

[11]  F. Sargolini,et al.  Role of dopaminergic system in reactivity to spatial and non-spatial changes in mice , 2000, Psychopharmacology.

[12]  D. Nutt,et al.  Novel Selective Compounds for the Investigation of Imidazoline Receptors a , 1999, Annals of the New York Academy of Sciences.

[13]  J. Welsh,et al.  Systemic harmaline blocks associative and motor learning by the actions of the inferior olive , 1998, The European journal of neuroscience.

[14]  J. Harvey,et al.  Acute inactivation of the inferior olive blocks associative learning , 1998, The European journal of neuroscience.

[15]  A. Usiello,et al.  N-methyl-D-aspartate and dopamine receptor involvement in the modulation of locomotor activity and memory processes , 1998, Experimental Brain Research.

[16]  M. Airaksinen,et al.  Binding of pinoline on the 5-hydroxytryptamine transporter: competitive interaction with [3H] citalopram. , 1997, Pharmacology & toxicology.

[17]  J. Harvey,et al.  Harmaline-induced tremor and impairment of learning are both blocked by dizocilpine in the rabbit , 1997, Brain Research.

[18]  R. D. Myers,et al.  Action of harman (1-methyl-β-carboline) on the brain: Body temperature and in vivo efflux of 5-HT from hippocampus of the rat , 1996, Neuropharmacology.

[19]  P. Maher,et al.  The Role of Monoamine Metabolism in Oxidative Glutamate Toxicity , 1996, The Journal of Neuroscience.

[20]  T. Kameyama,et al.  Effects of dynorphin A-(1-13) on carbon monoxide-induced delayed amnesia in mice studied in a step-down type passive avoidance task. , 1995, European journal of pharmacology.

[21]  J. Lehmann,et al.  Comparison of the in vitro binding characteristics of the β-carbolines harman and norharman in rat brain and liver and in bovine adrenal medulla , 1994, Naunyn-Schmiedeberg's Archives of Pharmacology.

[22]  R. Chemli,et al.  Peganum harmala L: a poisonous plant of North Africa. , 1991, Veterinary and human toxicology.

[23]  M. Pranzatelli,et al.  Harmala alkaloids and related β-carbolines: A myoclonic model and antimyoclonic drugs , 1987, Experimental Neurology.

[24]  J. C. Stoof,et al.  Two dopamine receptors: biochemistry, physiology and pharmacology. , 1984, Life sciences.

[25]  J. Hyttel.  Functional evidence for selective dopamine D-1 receptor blockade by SCH 23390 , 1984, Neuropharmacology.

[26]  P. B. Silverman,et al.  Effects of 6‐methoxytetrahydro‐β‐carboline on 5‐hydroxytryptamine binding in rat brain , 1984, The Journal of pharmacy and pharmacology.

[27]  H. Rommelspacher,et al.  1-Methyl-β-carboline (Harmane), a potent endogenous inhibitor of benzodiazepine receptor binding , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.

[28]  Y. Lamarre,et al.  Rhythmic activity induced by harmaline in the olivo-cerebello-bulbar system of the cat. , 1973, Brain research.

[29]  Y. Lamarre,et al.  Neurophysiological studies of harmaline-induced tremor in the cat. , 1971, Canadian journal of physiology and pharmacology.

[30]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[31]  J. Lizcano,et al.  Inhibition of monoamine oxidase from bovine retina by beta-carbolines. , 1994, The Journal of pharmacy and pharmacology.

[32]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[33]  Y. Mizoi,et al.  Determination of beta-carbolines in foodstuffs by high-performance liquid chromatography and high-performance liquid chromatography-mass spectrometry. , 1991, Journal of chromatography.

[34]  H. Rommelspacher,et al.  Beta-carbolines and tetrahydroisoquinolines: detection and function in mammals. , 1991, Planta medica.

[35]  J. Moncrieff.  Determination of pharmacological levels of harmane, harmine and harmaline in mammalian brain tissue, cerebrospinal fluid and plasma by high-performance liquid chromatography with fluorimetric detection. , 1989, Journal of chromatography.

[36]  L. Tuomisto,et al.  Tremorigenic effect and inhibition of tryptamine and serotonin receptor binding by beta-carbolines. , 1987, Pharmacology & toxicology.

[37]  H. Rommelspacher,et al.  Benzodiazepine antagonism by harmane and other beta-carbolines in vitro and in vivo. , 1981, European journal of pharmacology.

[38]  M. Airaksinen,et al.  Major pharmacological effects of 6-methoxytetrahydro-beta-carboline, a drug elevating the tissue 5-hydroxytryptamine level. , 1978, Arzneimittel-Forschung.